Clinical variables | OR | 95%CI | p |
---|---|---|---|
Univariate analyses | |||
Age | 1.01 | 0.99–1.03 | 0.30 |
Male gender | 1.14 | 0.63–2.08 | 0.65 |
RF | 1.33 | 0.77–2.32 | 0.31 |
ACPA | 0.73 | 0.45–1.28 | 0.20 |
Disease duration | 0.99 | 0.95–1.02 | 0.58 |
Extra-articular features | 1.67 | 0.94–2.93 | 0.08 |
Radiographic damage | 089 | 0.55–1.43 | 0.63 |
Joint surgery | 0.82 | 0.38–1.76 | 0.61 |
Maintenance of remission | 0.55 | 0.34–0.91 | 0.20 |
CRP | 1.02 | 0.99–1.05 | 0.14 |
BMI | 1.05 | 0.99–1.08 | 0.11 |
HBP | 10.69 | 5.06–22.59 | < 0.0001 |
High cholesterol | 2.47 | 0.56–5.9 | 0.18 |
Smoking habit | 0.80 | 0.47–1.35 | 0.40 |
MetS | 6.27 | 3.79–10.37 | < 0.0001 |
T2D | 2.64 | 1.48–4.71 | 0.001 |
ASA | 1.11 | 0.78–2.01 | 0.85 |
CCS | 1.44 | 0.81 | 2.56 |
CCSs low dosage | 1.91 | 0.89–3.46 | 0.09 |
MTX | 1.31 | 0.64–2.72 | 0.45 |
HCQ | 0.61 | 0.34–1.08 | 0.09 |
LEF | 0.51 | 0.25–1.07 | 0.07 |
SSZ | 0.53 | 0.23–1.24 | 0.14 |
Biologic DMARDs | 0.67 | 0.29–1.36 | 0.35 |
TNFi | 0.55 | 0.32–1.01 | 0.07 |
Non-TNFi | 0.59 | 0.31–1.02 | 0.09 |
Multivariate analysis | |||
Age | 1.01 | 0.99–1.05 | 0.44 |
Male gender | 0.62 | 0.22–1.73 | 0.36 |
HBP | 1.85 | 0.69–4.91 | 0.21 |
T2D | 6.21 | 2.19–17.71 | 0.001 |
Remission | 0.20 | 0.09–0.95 | 0.041 |